Status:
UNKNOWN
Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Gastric Cancer
Colorectal Cancer
Eligibility:
All Genders
Brief Summary
Gastric cancer and colorectal cancer are common gastrointestinal malignancies in the world.Early cancer generally has no obvious symptoms. Endoscopy is the "gold standard"for the diagnosis of gastric ...
Eligibility Criteria
Inclusion
- Patients who are scheduled for gastric tumor, colorectal tumor or bladder tumor resection Signed informed consent
Exclusion
- the vital signs are not stable unconscious unwilling to cooperate
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04385316
Start Date
September 1 2019
End Date
December 31 2020
Last Update
May 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Nanjing Medical Universit
Nanjing, Jiangsu, China, 210029